SOLCA Quito
SOLCA Quito is a nonprofit oncology hospital founded in 1954 in Quito, Ecuador, serving as the national reference center for comprehensive cancer care — including PET Scan, NGS, radiotherapy, and pediatric oncology — for approximately 8,000 patients monthly across four regional satellite units.
- Company typePrivate
- Founded1954
- HeadquartersQuito, Ecuador
- Headcount1,001–5,000
- GTM typeB2C
- OfferingServices
What SOLCA Quito does
SOLCA Quito (legal name Sociedad de Lucha contra el Cáncer, Núcleo de Quito) is a nonprofit oncology hospital founded on July 23, 1954, in Quito, Ecuador, operating as the country's national reference center for cancer care. The institution delivers comprehensive oncology services spanning clinical oncology, pediatric oncology, surgical oncology, radiotherapy, chemotherapy, oncohematology, palliative care, and bone marrow transplantation, supported by an integrated diagnostic platform that includes PET Scan (the most modern in Ecuador), Next-Generation Sequencing (NGS) for precision oncology, molecular biology and flow cytometry, nuclear medicine, imaging, pathology, and cytology. SOLCA Quito serves approximately 8,000 patients monthly with over 92,000 monthly attendances, including roughly 500 pediatric patients, and operates regional satellite units in Imbabura, Chimborazo, and Santo Domingo de los Tsáchilas.
The revenue model is built on four streams: services covered through public health insurance systems (Ministerio de Salud Pública / MSP, Instituto Ecuatoriano de Seguridad Social / IESS, Instituto de Seguridad Social de las Fuerzas Armadas / ISSFA, and Instituto de Seguridad Social de la Policía Nacional / ISSPOL), direct private/particular patient payments, charitable donations supporting pediatric care and infrastructure, and modest fees from the Centro de Hospitalidad (approximately $2 per day, with 40% of guests staying free). Patient demographics reveal structural geographic demand: 33% of patients travel from outside Quito and approximately 10% of provincial patients abandon treatment due to transportation and lodging barriers, motivating investment in satellite units and family accommodation. Public-facing pricing is limited, with disclosed fees including $12 USD for Papanicolaou cytology and $125 USD for HPV vaccination courses. The organization pursues international credibility through partnerships with St. Jude Children's Research Hospital, WHO/PAHO, UICC membership, and aspirational OECI Cancer Center certification, alongside ESG leadership via the 4,368-solar-panel clean energy installation completed in 2025.
SOLCA Quito firmographics
Firmographics- Name
- SOLCA Quito
- Legal name
- Sociedad de Lucha contra el Cáncer, Núcleo de Quito
- Website
- https://www.solcaquito.org.ec
- Company type
- Private
- Founded year
- 1954
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- SOLCA Quito is a nonprofit oncology hospital founded in 1954 in Quito, Ecuador, serving as the national reference center for comprehensive cancer care — including PET Scan, NGS, radiotherapy, and pediatric oncology — for approximately 8,000 patients monthly across four regional satellite units.
- Ownership category
- akta.pro rank
SOLCA Quito industry classification
Industry- Product category
- Oncology Hospital Services
- NAICS
- General Medical and Surgical Hospitals (622110)
- SIC
- Services-General Medical & Surgical Hospitals, Nec (8062), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)
- akta.pro secondary industry
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)
Keywords
Where SOLCA Quito is headquartered
LocationHeadquarters
- HQ city
- Quito
- HQ country
- Ecuador
- HQ region
- Latin America
Offices5 records
Markets served
SOLCA Quito business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others
Revenue model
- Public Health System Services: SOLCA Quito serves patients referred from public healthcare providers including the Ministry of Public Health (MSP), Ecuadorian Social Security Institute (IESS), Armed Forces Social Security (ISSFA), and National Police Social Security (ISSPOL). Services are covered through these public health insurance systems.
- Private/Particular Patient Services: Direct payment services for private patients not covered by public insurance, including executive rooms and private consultations
- Donations and Philanthropy: Charitable donations from individuals and organizations to support pediatric patients, hospitality center operations, and hospital improvements
- Hospitality Center Fees: Modest accommodation fees for family members of patients staying at Centro de Hospitalidad - approximately 40% stay free, 60% pay average $2 per day
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | One time/ perpetual license | HPV Vaccination for adults 18+ |
| Unit Pricing | One time/ perpetual license | Papanicolaou cytology screening |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels9 records
SOLCA Quito product offering
Product offeringCore offering
SOLCA Quito (Hospital Oncológico Solón Espinosa Ayala) is a national reference oncology hospital providing comprehensive cancer care from prevention through diagnosis, treatment, and palliative care. Core offerings include clinical oncology, pediatric oncology, surgical oncology, radiation therapy, chemotherapy, bone marrow transplantation, advanced diagnostics (PET Scan, NGS genetic sequencing, molecular biology, nuclear medicine), and preventive screening services. The institution operates under the nonprofit Sociedad de Lucha contra el Cáncer and serves patients referred from Ecuador's public health systems as well as private patients.
Product overview
SOLCA Quito is a specialized oncology hospital offering comprehensive cancer care through an integrated network of services. The hospital operates as a multi-specialty oncology center providing clinical oncology, pediatric oncology, oncological surgery, radiotherapy, and chemotherapy, supported by advanced diagnostic laboratories including molecular biology, genetics/genomics (NGS), flow cytometry, imaging, and nuclear medicine. The institution also provides bone marrow transplantation, palliative care, emergency services, and intensive care. Patient support is enhanced through executive rooms, a hospitality center for provincial families, volunteer services, and educational programs through hospital classrooms. SOLCA Quito positions itself as Ecuador's national reference hospital for oncology, supported by strategic partnerships with international institutions and participation in global cancer control initiatives.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Oncology (Oncología Clínica) Comprehensive clinical oncology services for the diagnosis and treatment of adult cancer patients across all oncology specialties.
- Pediatric Oncology (Oncología Pediátrica) Specialized oncology services for children and adolescents with cancer, including chemotherapy and hospitalization supported by renovated facilities. Approximately 500 patients treated monthly.
- Surgical Oncology (Cirugía Oncológica) Surgical oncology procedures for tumor removal and cancer treatment.
- Radiation Therapy (Radioterapia) Radiation therapy services for cancer treatment including external beam radiation and MRI-guided brachytherapy (first in Ecuador).
- Outpatient Chemotherapy (Quimioterapia Ambulatoria) Outpatient chemotherapy services allowing patients to receive cancer treatment without overnight hospitalization.
- PET Scan Service Advanced PET Scan imaging for cancer diagnosis and high-precision monitoring, the most modern in Ecuador.
- Next-Generation Sequencing (NGS) Massive parallel sequencing panels for precision oncology including hematological neoplasms, solid tumors, and pediatric cancers. Identifies mutations and genetic alterations for diagnosis, monitoring, prognosis, and personalized treatment.
- Molecular Biology and Flow Cytometry Laboratory Comprehensive diagnostic laboratory for immunophenotyping in oncohematology, including leukemia, lymphoma, myeloma, and stem cell quantification.
- Genetics and Genomics Unit Genetic and genomic testing unit for hereditary cancer risk assessment and genetic counseling.
- Nuclear Medicine (Medicina Nuclear) Nuclear medicine services for diagnostic imaging and targeted cancer treatments.
- Bone Marrow Transplant (Trasplante de Médula Ósea) Bone marrow transplant service including autologous transplantation with CD34+ stem cell quantification.
- Oncohematology Oncohematology services for blood cancer diagnosis and treatment including leukemias and lymphomas.
- Palliative Care (Cuidados Paliativos) Palliative care services for improving quality of life for cancer patients.
- Preventive Oncology Check-up (Chequeo Oncológico Preventivo) Preventive oncology check-up program for early cancer detection and health promotion.
- Hospitalization (Hospitalización) Inpatient hospital services for cancer treatment and recovery.
- Executive Rooms (Habitaciones Ejecutivas) Premium accommodation for private patients with solar panels and heat pump systems for hot water generation.
- Hospitality Center (Centro de Hospitalidad)
- Hospital Classroom Program (Aulas Hospitalarias) Educational program ensuring continuity of education for pediatric oncology patients under 18 years, benefiting over 21,960 patients since 2006.
- Radial EBUS for Lung Diagnosis First-in-Ecuador radial endobronchial ultrasound for diagnosing peripheral lung lesions as small as 6mm, increasing early cancer detection by 10-20%.
- MRI-Guided Brachytherapy First-in-Ecuador MRI-guided brachytherapy, a less invasive, precise, and curative cancer treatment.
Quantifiable outcome
- More than 1,000 in situ and initial cancers detected since 2014
- +5 more outcomes
Companies that use SOLCA Quito
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles2 records
SOLCA Quito technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability2 records
Feature6 records
SOLCA Quito partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- Organización Mundial de la Salud (OMS) / Organización Panamericana de la Salud (OPS)coreOfficial partnership through Global Alliance Against Childhood Cancer along with Ministry of Health and St. Jude Children's Research Hospital for improving access to childhood cancer medicines.
- TradecuscorePartnership to provide UpToDate clinical reference platform - one of the most reliable and widely used clinical reference tools globally. Supports evidence-based medical decision making for healthcare professionals.
- Instituto Europeo de Posgrado (IEP)coreEducational partnership allowing SOLCA Quito staff access to high-quality online academic programs. Supports continuous professional development in medical and administrative areas.
- St. Jude Children's Research HospitalcorePartnership through the Global Platform for Access to Childhood Cancer Medicines (GPACCM) with WHO, PAHO and Ministry of Health. Also provides international recognition for pediatrics team as PrOFILE Implementation Ambassadors.
- Union for International Cancer Control (UICC)coreSOLCA Quito is an active member of UICC, connecting with the global cancer control community and accessing international resources, guidelines, and best practices for oncology care.
- Banco del AustrocoreStrategic alliance for pediatric area renovation. Funded the ambientation and renewal of pediatric outpatient consultation, ambulatory chemotherapy and hospitalization areas. Created superhero mascots (Sol, Luna, Estrellita, Solkyn, Darwin, Robtiquín) for pediatric patients.
- Fundación Prosperar SaludcoreFoundation supports the Centro de Hospitalidad operations for accommodating family members of provincial patients with limited resources.
- Instituto Oncológico Fundación Arturo López Pérez (FALP)minorFALP, the only Latin American center accredited as Cancer Center by OECI, visited SOLCA Quito to learn processes and protocols. Collaboration aimed at achieving international certifications.
- Universidad IndoaméricacorePartnership to equip a teaching classroom with state-of-the-art technology as part of agreements strengthening oncology postgraduate training. Also provides academic endorsement for medical symposia.
- Andes PetroleumminorCorporate partner for the 'Mujeres emprendedoras' (Enterprising Women) project in collaboration with Fundación Junior Achievement and SOLCA Quito, supporting 30 women including mothers, relatives and patients.
- Fundación Junior AchievementminorPartnership for the 'Mujeres emprendedoras' project supporting women entrepreneurship skills development for patients and family members.
Scale indicators13 records
Recent moves12 records
Expansion highlights6 records
SOLCA Quito competitors and assessment
Company assessmentDirect peers
- Instituto Oncológico Fundación Arturo López Pérez (FALP): Chilean nonprofit oncology center and the only Latin American institution accredited as a Cancer Center by OECI. Directly comparable to SOLCA Quito as a comprehensive, research-active cancer hospital in the Andean region; FALP has actively collaborated with SOLCA Quito on OECI certification pathways.
- Instituto Nacional de Cancerología (INC Colombia): Colombia's national reference cancer hospital, offering comprehensive oncology services with strong research and teaching programs. Comparable to SOLCA Quito as a publicly-affiliated national oncology reference center in Latin America serving both insured and vulnerable populations.
- A.C. Camargo Cancer Center: Brazilian comprehensive cancer center providing integrated oncology diagnosis, treatment, research and education. Comparable to SOLCA Quito in scale and scope of services across prevention, surgery, radiotherapy, chemotherapy and advanced diagnostics.
- Hospital de Câncer de Barretos: Large Brazilian oncology hospital known for high-volume cancer care, prevention programs and international partnerships. Comparable to SOLCA Quito in serving a broad patient base with extensive outreach, satellite units, and pediatric oncology capacity.
- Hospital de Oncología María Curie: Argentine specialized oncology hospital providing comprehensive cancer care including surgery, chemotherapy, radiotherapy and palliative care. Comparable to SOLCA Quito in mission and service mix, though smaller in scale.
Broad incumbents
- Oncosalud / Auna: Peruvian oncology-focused healthcare network providing prevention, diagnosis and treatment across multiple sites. Comparable to SOLCA Quito in oncology specialization and multi-site delivery model, with stronger commercial scale and payor integration.
- Hospital Italiano de Buenos Aires: Large Argentine academic hospital with a strong oncology service line and research/teaching capabilities. Comparable to SOLCA Quito as a teaching hospital with advanced diagnostics, though oncology is one of several service lines rather than the sole focus.
- MD Anderson Cancer Center: Global benchmark for integrated oncology care, research and education. Comparable to SOLCA Quito in offering comprehensive cancer services across the continuum of care; SOLCA Quito cites MD Anderson-style standards in its pursuit of OECI certification.
Others
- St. Jude Children's Research Hospital: Global pediatric oncology reference and SOLCA Quito's international partner through the Global Platform for Access to Childhood Cancer Medicines. Comparable as a research-intensive pediatric oncology institution and partner in protocol/prOFILE implementation.
Regional players
- Centro Médico Nacional Siglo XXI (IMSS): Mexican public reference hospital complex with significant oncology services tied to social security. Comparable to SOLCA Quito as a public-payor-anchored national cancer referral institution, though operating in a different (and larger) healthcare system.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat7 records
Key risks5 records
Key highlights7 records
Customer concentration
SOLCA Quito social profiles
Digital presenceSOLCA Quito compliance and trust
Trust signalCompliance8 records
SOLCA Quito financial estimates
Financial estimateRevenue estimate
Valuation estimate
SOLCA Quito leadership team
Management profileNumber of profiles
Profiles9 records
SOLCA Quito subsidiaries and ownership
Company hierarchySubsidiaries3 records
SOLCA Quito funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SOLCA Quito M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SOLCA Quito
What does SOLCA Quito do?
SOLCA Quito (Hospital Oncológico Solón Espinosa Ayala) is a national reference oncology hospital providing comprehensive cancer care from prevention through diagnosis, treatment, and palliative care. Core offerings include clinical oncology, pediatric oncology, surgical oncology, radiation therapy, chemotherapy, bone marrow transplantation, advanced diagnostics (PET Scan, NGS genetic sequencing, molecular biology, nuclear medicine), and preventive screening services. The institution operates under the nonprofit Sociedad de Lucha contra el Cáncer and serves patients referred from Ecuador's public health systems as well as private patients.
Is SOLCA Quito a public or private company?
SOLCA Quito is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was SOLCA Quito founded?
SOLCA Quito was founded in 1954. It employs 1,001 to 5,000 people.
Where is SOLCA Quito based?
SOLCA Quito is headquartered in Quito, Ecuador, in the Latin America region.
How does SOLCA Quito make money?
Four revenue lines are on record. Public Health System Services are the primary driver. The others are private/Particular Patient Services, donations and Philanthropy and hospitality Center Fees.
Who are SOLCA Quito's main competitors?
Direct peers on record are Instituto Oncológico Fundación Arturo López Pérez (FALP), Instituto Nacional de Cancerología (INC Colombia), A.C. Camargo Cancer Center, Hospital de Câncer de Barretos and Hospital de Oncología María Curie. Broad incumbents are Oncosalud / Auna, Hospital Italiano de Buenos Aires and MD Anderson Cancer Center. St. Jude Children's Research Hospital is listed as an others. Centro Médico Nacional Siglo XXI (IMSS) is listed as a regional player.
Does SOLCA Quito have an API?
No public API is recorded for SOLCA Quito.
What industry is SOLCA Quito in?
SOLCA Quito's product category is Oncology Hospital Services. Its primary akta.pro industry code is HLAFAAAM, Hospital-Integrated Cancer Centers (Acute Oncology Programs), with a secondary code of HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation). Its NAICS code is 622110 and its SIC code is 8062.